9th Circ. Revives Amgen Drug Rebates Dispute

Amgen Inc. is back on the hook in a contract suit brought by an oncology center over drug rebates, with the U.S. Court of Appeals for the Ninth Circuit reversing an...

Already a subscriber? Click here to view full article